Literature DB >> 18971399

Focus on alcohol & drug abuse: improving service delivery for individuals with co-occurring disorders: new perspectives on the quadrant model.

Donna J Keyser1, Katherine E Watkins, Anna-Marie Vilamovska, Harold Alan Pincus.   

Abstract

This column summarizes findings of a study that examined the usefulness of the quadrant model for improving service delivery for persons with co-occurring disorders. The authors discuss treatment recommendations, goals and barriers related to delivering care, policy recommendations for implementing evidence-based interventions, and strengths and limitations of the model. They conclude that although the quadrant model is useful for conceptualizing systems-level factors for improving delivery, its further development is unlikely to result in improved care at the clinical level. They call for research to develop and implement evidence-based practices targeted to specific populations of persons with co-occurring disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18971399      PMCID: PMC6545908          DOI: 10.1176/ps.2008.59.11.1251

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  3 in total

1.  Differential service utilization associated with trauma-informed integrated treatment for women with co-occurring disorders.

Authors:  Allison R Gilbert; Marisa E Domino; Joseph P Morrissey; Bradley N Gaynes
Journal:  Adm Policy Ment Health       Date:  2012-11

2.  Psychosocial Treatment of Bipolar Disorder: Clinician Knowledge, Common Approaches, and Barriers to Effective Treatment.

Authors:  Bradley D Stein; Karen L Celedonia; Holly A Swartz; Rachel M Burns; Mark J Sorbero; Rayni A Brindley; Ellen Frank
Journal:  Psychiatr Serv       Date:  2015-09-01       Impact factor: 3.084

Review 3.  Concurrent Disorder Management Guidelines. Systematic Review.

Authors:  Syune Hakobyan; Sara Vazirian; Stephen Lee-Cheong; Michael Krausz; William G Honer; Christian G Schutz
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.